Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Leishmania Amazonensis
100%
Interferon-γ
100%
CXCL10
100%
Interferon-inducible Protein 10
100%
C57BL
60%
Monocyte Chemoattractant protein-1 (MCP-1)
40%
Parasite Burden
40%
Cell Function
20%
Fold Increase
20%
Therapeutic Control
20%
Non-healing
20%
Effector Cells
20%
Macrophages
20%
Interleukin-4 (IL-4)
20%
Cutaneous Leishmaniasis
20%
Effector Function
20%
Chemokines
20%
Chemokine (C-C motif) Ligand 2 (CCL2)
20%
Interleukin-12 (IL-12)
20%
Progressive Disease
20%
Dose Effect
20%
Pathogenic Mechanism
20%
Inflammatory Chemokines
20%
Protective Behavior
20%
Nitric Oxide Production
20%
Inbred Strains
20%
Lesion Development
20%
Promastigote
20%
Amastigote
20%
Early Response
20%
IL-10 Production
20%
Leukocyte Recruitment
20%
Bone Marrow-derived Macrophages
20%
Lymph Node Cells
20%
Stationary Phase
20%
Antigen-specific CD4 T Cells
20%
Recombinant Chemokines
20%
Intracellular Parasites
20%
Immunology and Microbiology
Leishmania amazonensis
100%
CXCL10
100%
Gamma Interferon Inducible Protein 10
100%
Infection
100%
Chemokine
50%
C57BL 6 Mouse
50%
Parasite Load
33%
Monocyte Chemotactic Protein 1
33%
Cell Function
16%
Proinflammatory Cytokine
16%
Cutaneous Leishmaniasis
16%
Effector Cell
16%
Macrophage
16%
Antigen Specificity
16%
T-Helper Cell
16%
Secretion (Process)
16%
Mediator
16%
CCL2
16%
Interleukin 4
16%
Interleukin 10
16%
Intracellular Parasite
16%
Promastigote
16%
Inbred Strain
16%
Amastigote
16%
Interferon Gamma
16%
Lymph Node Cell
16%
Bone Marrow-Derived Macrophage
16%
Leukocyte Recruitment
16%
In Vitro
16%